Skip to main content
. Author manuscript; available in PMC: 2018 Jun 15.
Published in final edited form as: Clin Cancer Res. 2016 Dec 8;23(12):3003–3011. doi: 10.1158/1078-0432.CCR-16-2267

Figure 3. Dovitinib pFGFR3 IHC Pathology Samples. A) Patient 3 – Baseline. B) Patient 3 – Post-treatment cycle 3 day 26.

Figure 3

(pFGFR3 = Phosphorylated FGFR3, IHC = Immunohistochemistry)